4otk
From Proteopedia
(Difference between revisions)
| Line 1: | Line 1: | ||
| + | |||
==A structural characterization of the isoniazid Mycobacterium tuberculosis drug target, Rv2971, in its unliganded form== | ==A structural characterization of the isoniazid Mycobacterium tuberculosis drug target, Rv2971, in its unliganded form== | ||
<StructureSection load='4otk' size='340' side='right' caption='[[4otk]], [[Resolution|resolution]] 1.60Å' scene=''> | <StructureSection load='4otk' size='340' side='right' caption='[[4otk]], [[Resolution|resolution]] 1.60Å' scene=''> | ||
| Line 4: | Line 5: | ||
<table><tr><td colspan='2'>[[4otk]] is a 1 chain structure. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=4OTK OCA]. For a <b>guided tour on the structure components</b> use [http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=4OTK FirstGlance]. <br> | <table><tr><td colspan='2'>[[4otk]] is a 1 chain structure. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=4OTK OCA]. For a <b>guided tour on the structure components</b> use [http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=4OTK FirstGlance]. <br> | ||
</td></tr><tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat"><scene name='pdbligand=CL:CHLORIDE+ION'>CL</scene>, <scene name='pdbligand=MLI:MALONATE+ION'>MLI</scene></td></tr> | </td></tr><tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat"><scene name='pdbligand=CL:CHLORIDE+ION'>CL</scene>, <scene name='pdbligand=MLI:MALONATE+ION'>MLI</scene></td></tr> | ||
| - | <tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=4otk FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=4otk OCA], [http://www.rcsb.org/pdb/explore.do?structureId=4otk RCSB], [http://www.ebi.ac.uk/pdbsum/4otk PDBsum]</span></td></tr> | + | <tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=4otk FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=4otk OCA], [http://pdbe.org/4otk PDBe], [http://www.rcsb.org/pdb/explore.do?structureId=4otk RCSB], [http://www.ebi.ac.uk/pdbsum/4otk PDBsum], [http://prosat.h-its.org/prosat/prosatexe?pdbcode=4otk ProSAT]</span></td></tr> |
</table> | </table> | ||
<div style="background-color:#fffaf0;"> | <div style="background-color:#fffaf0;"> | ||
| Line 14: | Line 15: | ||
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.<br> | From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.<br> | ||
</div> | </div> | ||
| + | <div class="pdbe-citations 4otk" style="background-color:#fffaf0;"></div> | ||
== References == | == References == | ||
<references/> | <references/> | ||
Revision as of 19:24, 11 August 2016
A structural characterization of the isoniazid Mycobacterium tuberculosis drug target, Rv2971, in its unliganded form
| |||||||||||
